Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

(CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.

ClinicalTrials.gov ID: NCT00801723

Public ClinicalTrials.gov record NCT00801723. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 2:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomised, Double-Blind, Multi-Centre, 12 Month Extension Study to Evaluate the Safety And Efficacy of Daily Budesonide MMX 6 mg Versus Placebo in the Maintenance of Remission in Subjects With Ulcerative Colitis.

Study identification

NCT ID
NCT00801723
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
123 participants

Conditions and interventions

Interventions

  • Budesonide MMX 6 mg Tablet Drug
  • Placebo Tablet Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2008
Primary completion
Apr 30, 2011
Completion
May 31, 2011
Last update posted
Aug 30, 2020

2008 – 2011

United States locations

U.S. sites
53
U.S. states
19
U.S. cities
49
Facility City State ZIP Site status
Santarus Clinical Investigational Site 5051 Huntsville Alabama 35801
Santarus Clinical Investigational Site 5088 Tucson Arizona 85712
Santarus Clinical Investigational Site 5044 Anaheim California 92801
Santarus Clinical Investigational Site 5087 Lakewood California 90712
Santarus Clinical Investigational Site 5033 Los Angeles California 90045
Santarus Clinical Investigational Site 5070 Palm Springs California 92262
Santarus Clinical Investigational Site 5067 San Diego California 92101
Santarus Clinical Investigational Site 5064 Lakewood Colorado 80215
Santarus Clinical Investigational Site 5089 Boynton Beach Florida 33426
Santarus Clinical Investigational Site 5041 Hollywood Florida 33021
Santarus Clinical Investigational Site 5055 New Smyrna Beach Florida 32168
Santarus Clinical Investigational Site 5074 Port Orange Florida 32127
Santarus Clinical Investigational Site 5032 Tampa Florida 33607
Santarus Clinical Investigational Site 5009 Tampa Florida 33613
Santarus Clinical Investigational Site 5047 Winter Park Florida 32789
Santarus Clinical Investigational Site 5003 Zephyrhills Florida 33542
Santarus Clinical Investigational Site 5016 Atlanta Georgia 30312
Santarus Clinical Investigational Site 5056 Columbus Georgia 31904
Santarus Clinical Investigational Site 5068 Evanston Illinois 60201
Santarus Clinical Investigational Site 5008 Metairie Louisiana 70006
Santarus Clinical Investigational Site 5090 Annapolis Maryland 21401
Santarus Clinical Investigational Site 5025 Baltimore Maryland 21229
Santarus Clinical Investigational Site 5092 Hollywood Maryland 20636
Santarus Clinical Investigational Site 5077 Prince Frederick Maryland 20678
Santarus Clinical Investigational Site 5010 Chesterfield Michigan 48047
Santarus Clinical Investigational Site 5006 Troy Michigan 48098
Santarus Clinical Investigational Site 5004 Wyoming Michigan 49519
Santarus Clinical Investigational Site 5005 Marlton New Jersey 08053
Santarus Clinical Investigational Site 5011 Great Neck New York 11021
Santarus Clinical Investigational Site 5101 New York New York 10016
Santarus Clinical Investigational Site 5020 Pittsford New York 14534
Santarus Clinical Investigational Site 5096 Fayetteville North Carolina 28304
Santarus Clinical Investigational Site 5058 Huntersville North Carolina 28078
Santarus Clinical Investigational Site 5091 New Bern North Carolina 28562
Santarus Clinical Investigational Site 5045 Cincinnati Ohio 45219
Santarus Clinical Investigational Site 5078 Dayton Ohio 45440
Santarus Clinical Investigational Site 5001 Yukon Oklahoma 73099
Santarus Clinical Investigational Site 5066 Duncansville Pennsylvania 16635
Santarus Clinical Investigational Site 5065 Pottstown Pennsylvania 19464
Santarus Clinical Investigational Site 5035 Sayre Pennsylvania 18840
Santarus Clinical Investigational Site 5021 Austin Texas 78745
Santarus Clinical Investigational Site 5076 Houston Texas 77034
Santarus Clinical Investigational Site 5019 Houston Texas 77090
Santarus Clinical Investigational Site 5036 Houston Texas 77090
Santarus Clinical Investigational Site 5063 Irving Texas 75061
Santarus Clinical Investigational Site 5072 Kingwood Texas 77339
Santarus Clinical Investigational Site 5054 La Porte Texas 77571
Santarus Clinical Investigational Site 5030 Lewisville Texas 75057
Santarus Clinical Investigational Site 5093 Plano Texas 75075
Santarus Clinical Investigational Site 5100 San Antonio Texas 78229
Santarus Clinical Investigational Site 5079 San Antonio Texas 78258
Santarus Clinical Investigational Site 5015 Salt Lake City Utah 84107
Santarus Clinical Investigational Site 5097 Christiansburg Virginia 24073

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00801723, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 30, 2020 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00801723 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →